Objective: This paper aims to provide an overview of the current knowledge on neuroleptic-
induced tardive dyskinesia (TD) in relation to its clinical features, risk factors …

This systematic review aimed to collate randomized controlled trials (RCTs) of various
interventions used to treat tardive dyskinesia (TD) and, where appropriate, to combine the …

Tardive Dyskinesia (TD) can occur in people exposed to dopamine receptor antagonists
(DRAs). Its clinical management remains challenging. We conducted a systematic …

BACKGROUND Antipsychotic medication can cause tardive dyskinesia (TD)-late-onset,
involuntary, repetitive movements, often involving the face and tongue. TD occurs in> 20% of …

Objectives The aim of this study is to indirectly compare and rank the different drugs that
have been studied in randomized clinical trials (RCTs) in patients with tardive dyskinesia …

Background Tardive dyskinesia (TD) is a disabling movement disorder associated with the
prolonged use of antipsychotic medication. Several strategies have been examined in the …

Objective: About 20 percent of patients receiving long-term treatment with neuroleptic
medications develop tardive dyskinesia. A 1988 review of treatment studies for the disorder …

We have examined the effects of sulpiride, oxypertine and haloperidol on the bevavioral and
biochemical dopamine receptor function in the rat striatum. Although acute treatment with …

Publisher Summary Antipsychotic drugs affect various organs and systems including
cardiovascular, nervous system, allergic reactions as well as hip fracture. Peptide hormones …